Dexiang Gao Selected Research

Dexiang Gao Research Topics

Disease

29	Neoplasms (Cancer) 11/2023 - 05/2010
9	Melanoma (Melanoma, Malignant) 01/2023 - 07/2012
8	Squamous Cell Carcinoma of Head and Neck 11/2023 - 02/2016
7	Breast Neoplasms (Breast Cancer) 06/2023 - 04/2013
7	Lung Neoplasms (Lung Cancer) 11/2022 - 08/2012
5	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2020 - 10/2016
4	Down Syndrome (Down's Syndrome) 07/2023 - 08/2017
4	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 08/2010
4	Renal Cell Carcinoma (Grawitz Tumor) 01/2021 - 12/2012
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2022 - 08/2012
3	Triple Negative Breast Neoplasms 01/2021 - 01/2018
3	Disease Progression 12/2019 - 01/2016
3	Prostatic Neoplasms (Prostate Cancer) 12/2018 - 04/2012
3	Adenocarcinoma 01/2018 - 08/2012
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 04/2022 - 09/2020
2	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2021
2	Brain Neoplasms (Brain Tumor) 01/2020 - 05/2010
2	Obesity 01/2019 - 08/2006
2	Hypothyroidism 12/2016 - 12/2012
2	Wounds and Injuries (Trauma) 02/2016 - 06/2014
2	Infections 06/2014 - 12/2005
1	Central Nervous System Diseases (CNS Diseases) 06/2023
1	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 01/2023
1	Rhabdomyosarcoma 01/2023
1	Inflammation (Inflammations) 01/2023
1	Polyps 01/2023
1	Ewing Sarcoma (Sarcoma, Ewing) 01/2023
1	Pneumonia (Pneumonitis) 01/2022
1	Neuroinflammatory Diseases 01/2022
1	Radiation Pneumonitis 01/2022
1	Malaria 10/2021
1	Muscular Diseases (Myopathy) 10/2021
1	Hereditary Neoplastic Syndromes (Cancer Syndrome, Hereditary) 01/2021
1	Testicular Neoplasms (Testicular Cancer) 10/2020

Drug/Important Bio-Agent (IBA)

11	Biomarkers (Surrogate Marker)IBA 01/2020 - 08/2010
8	Messenger RNA (mRNA)IBA 01/2023 - 06/2014
6	Tyrosine Kinase InhibitorsIBA 12/2022 - 12/2012
5	Proteins (Proteins, Gene)FDA Link 11/2023 - 06/2014
3	LigandsIBA 11/2023 - 01/2016
3	pembrolizumabIBA 01/2023 - 01/2021
3	ErbB Receptors (EGF Receptor)IBA 01/2021 - 08/2012
3	ponatinibIBA 01/2019 - 06/2014
2	B7-H1 AntigenIBA 11/2023 - 01/2017
2	enzalutamideIBA 05/2023 - 01/2021
2	AndrogensIBA 05/2023 - 01/2021
2	Immune Checkpoint InhibitorsIBA 04/2022 - 01/2021
2	Interleukin-2 (IL2)IBA 01/2022 - 09/2014
2	Hormones (Hormone)IBA 01/2021 - 12/2020
2	Aldehyde DehydrogenaseIBA 12/2019 - 01/2017
2	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 01/2019 - 01/2018
2	MicroRNAs (MicroRNA)IBA 01/2018 - 01/2018
2	Sunitinib (Sutent)FDA Link 12/2016 - 12/2012
2	TankyrasesIBA 05/2016 - 08/2012
2	Irinotecan (Camptosar)FDA LinkGeneric 05/2016 - 06/2012
2	Indicators and Reagents (Reagents)IBA 01/2016 - 07/2012
2	Oxygen (Dioxygen)IBA 09/2012 - 11/2004
1	Programmed Cell Death 1 ReceptorIBA 11/2023
1	InterferonsIBA 07/2023
1	tucatinibIBA 06/2023
1	palbociclibIBA 06/2023
1	Cyclin D1IBA 06/2023
1	Letrozole (Femara)FDA LinkGeneric 06/2023
1	Aromatase InhibitorsIBA 06/2023
1	Fulvestrant (Faslodex)FDA Link 05/2023
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2023
1	Immunotoxins (Immunotoxin)IBA 01/2023
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2023
1	Circulating Tumor DNAIBA 11/2022
1	Pregnenolone Carbonitrile (PCN)IBA 11/2022
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2022
1	Vascular Endothelial Growth Factor CIBA 04/2022
1	Ifosfamide FDA LinkGeneric 10/2021
1	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2021
1	Vincristine (Oncovin)FDA LinkGeneric 10/2021
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2021
1	Ivermectin (Mectizan)FDA Link 10/2021
1	Calcibiotic Root Canal SealerIBA 01/2021
1	IpilimumabIBA 01/2021
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2021
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2021
1	Epidermal Growth Factor (EGF)IBA 01/2021
1	HLA-A Antigens (HLA-A)IBA 01/2021
1	atezolizumabIBA 01/2021
1	Diphtheria ToxinIBA 01/2021
1	Axitinib (AG 013736)IBA 01/2021
1	Interferon-gamma (Interferon, gamma)IBA 01/2021
1	NivolumabIBA 01/2021
1	abirateroneIBA 01/2021
1	avelumabIBA 01/2021

Therapy/Procedure

20	Therapeutics 06/2023 - 12/2005
7	Immunotherapy 01/2023 - 10/2012
6	Drug Therapy (Chemotherapy) 01/2022 - 05/2010
4	Radiotherapy 01/2023 - 01/2018
4	Tonsillectomy 01/2019 - 10/2012
3	Aftercare (After-Treatment) 02/2016 - 06/2012
1	Surgical Instruments (Clip) 01/2023
1	Brachytherapy 01/2022
1	Chemoradiotherapy 01/2022
1	Mass Drug Administration 10/2021
1	Orchiopexy 10/2020